Login / Signup
Tenascin-C, a novel target to inhibit new bone formation in axial spondyloarthritis, linked with inflammation, mechanical strain and tissue damage.
Margot Van Mechelen
Rik Ju Lories
Published in:
Annals of the rheumatic diseases (2021)
Keyphrases
</>
oxidative stress
ankylosing spondylitis
disease activity